{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:54:34Z","timestamp":1791003274049,"version":"4.1.0"},"reference-count":22,"publisher":"Japanese Society of Toxicology","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2131\/jts.51.549","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:15:13Z","timestamp":1790806513000},"page":"549-555","source":"Crossref","is-referenced-by-count":0,"title":["Whole-genome sequencing-based profiling of &lt;i&gt;CYP2D6&lt;\/i&gt; structural variants in Japanese patients with solid tumors"],"prefix":"10.2131","volume":"51","author":[{"given":"Sumiko","family":"Ohnami","sequence":"first","affiliation":[{"name":"Cancer Diagnostic Research Division, Shizuoka Cancer Center Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nagashima","sequence":"additional","affiliation":[{"name":"Cancer Diagnostic Research Division, Shizuoka Cancer Center Research Institute"},{"name":"SRL Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Hatakeyama","sequence":"additional","affiliation":[{"name":"Cancer Multiomics Division, Shizuoka Cancer Center Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouji","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Experimental Animal Facility, Shizuoka Cancer Center Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Mizuguchi","sequence":"additional","affiliation":[{"name":"Cancer Diagnostic Research Division, Shizuoka Cancer Center Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sou","family":"Nakatani","sequence":"additional","affiliation":[{"name":"Cancer Diagnostic Research Division, Shizuoka Cancer Center Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fukumi","family":"Kamada","sequence":"additional","affiliation":[{"name":"Cancer Diagnostic Research Division, Shizuoka Cancer Center Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Shimoda","sequence":"additional","affiliation":[{"name":"Cancer Diagnostic Research Division, Shizuoka Cancer Center Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Ohshima","sequence":"additional","affiliation":[{"name":"Medical Genetics Division, Shizuoka Cancer Center Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Urakami","sequence":"additional","affiliation":[{"name":"Cancer Diagnostic Research Division, Shizuoka Cancer Center Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumpei","family":"Ohnami","sequence":"additional","affiliation":[{"name":"Cancer Diagnostic Research Division, Shizuoka Cancer Center Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Shizuoka Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Charnaud, S., Munro, J.E., Semenec, L., Mazhari, R., Brewster, J., Bourke, C., Ruybal-Pes\u00e1ntez, S., James, R., Lautu-Gumal, D., Karunajeewa, H., Mueller, I. and Bahlo, M. (2022): PacBio long-read amplicon sequencing enables scalable high-resolution population allele typing of the complex CYP2D6 locus. Commun. Biol., <b>5<\/b>, 168.","DOI":"10.1038\/s42003-022-03102-8"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Favero, F., Joshi, T., Marquard, A.M., Birkbak, N.J., Krzystanek, M., Li, Q., Szallasi, Z. and Eklund, A.C. (2015): Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data. Ann. Oncol., <b>26<\/b>, 64-70.","DOI":"10.1093\/annonc\/mdu479"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Fukunaga, K., Hishinuma, E., Hiratsuka, M., Kato, K., Okusaka, T., Saito, T., Ikeda, M., Yoshida, T., Zembutsu, H., Iwata, N. and Mushiroda, T. (2021): Determination of novel CYP2D6 haplotype using the targeted sequencing followed by the long-read sequencing and the functional characterization in the Japanese population. J. Hum. Genet., <b>66<\/b>, 139-149.","DOI":"10.1038\/s10038-020-0815-x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Gaedigk, A., Bradford, L.D., Alander, S.W. and Leeder, J.S. (2006): CYP2D6*36 gene arrangements within the cyp2d6 locus: association of CYP2D6*36 with poor metabolizer status. Drug Metab. Dispos., <b>34<\/b>, 563-569.","DOI":"10.1124\/dmd.105.008292"},{"key":"5","doi-asserted-by":"crossref","unstructured":"He, W., Grassmann, F., Eriksson, M., Eliasson, E., Margolin, S., Thor\u00e9n, L., Hall, P. and Czene, K. (2020): CYP2D6 genotype predicts tamoxifen discontinuation and prognosis in patients with breast cancer. J. Clin. Oncol., <b>38<\/b>, 548-557.","DOI":"10.1200\/JCO.19.01535"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Hosono, N., Kato, M., Kiyotani, K., Mushiroda, T., Takata, S., Sato, H., Amitani, H., Tsuchiya, Y., Yamazaki, K., Tsunoda, T., Zembutsu, H., Nakamura, Y. and Kubo, M. (2009): CYP2D6 genotyping for functional-gene dosage analysis by allele copy number detection. Clin. Chem., <b>55<\/b>, 1546-1554.","DOI":"10.1373\/clinchem.2009.123620"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Jarvis, J.P., Peter, A.P. and Shaman, J.A. (2019): Consequences of CYP2D6 copy-number variation for pharmacogenomics in psychiatry. Front. Psychiatry, <b>10<\/b>, 432.","DOI":"10.3389\/fpsyt.2019.00432"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Kisoi, M., Imai, M., Yamamura, M., Sakaguchi, Y., Murata, S., Ichikawa, A. and Kinoshita, K. (2020): Unique genotyping protocol of CYP2D6 allele frequency using real time quantitative PCR from Japanese healthy women. Biol. Pharm. Bull., <b>43<\/b>, 904-907.","DOI":"10.1248\/bpb.b19-00512"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Kiyotani, K., Mushiroda, T., Zembutsu, H. and Nakamura, Y. (2013): Important and critical scientific aspects in pharmacogenomics analysis: lessons from controversial results of tamoxifen and CYP2D6 studies. J. Hum. Genet., <b>58<\/b>, 327-333.","DOI":"10.1038\/jhg.2013.39"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Kurose, K., Sugiyama, E. and Saito, Y. (2012): Population differences in major functional polymorphisms of pharmacokinetics\/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug development. Drug Metab. Pharmacokinet., <b>27<\/b>, 9-54.","DOI":"10.2133\/dmpk.DMPK-11-RV-111"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Molden, E. and Juki\u0107, M.M. (2021): CYP2D6 reduced function variants and genotype\/phenotype translations of CYP2D6 intermediate metabolizers: implications for personalized drug dosing in psychiatry. Front. Pharmacol., <b>12<\/b>, 650750.","DOI":"10.3389\/fphar.2021.650750"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Nagashima, T., Yamaguchi, K., Urakami, K., Shimoda, Y., Ohnami, S., Ohshima, K., Tanabe, T., Naruoka, A., Kamada, F., Serizawa, M., Hatakeyama, K., Matsumura, K., Ohnami, S., Maruyama, K., Mochizuki, T., Kusuhara, M., Shiomi, A., Ohde, Y., Terashima, M., Uesaka, K., Onitsuka, T., Nishimura, S., Hirashima, Y., Hayashi, N., Kiyohara, Y., Tsubosa, Y., Katagiri, H., Niwakawa, M., Takahashi, K., Kashiwagi, H., Nakagawa, M., Ishida, Y., Sugino, T., Takahashi, M. and Akiyama, Y. (2020): Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients. Cancer Sci., <b>111<\/b>, 687-699.","DOI":"10.1111\/cas.14290"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Nagashima, T., Yamaguchi, K., Urakami, K., Shimoda, Y., Ohnami, S., Ohshima, K., Tanabe, T., Naruoka, A., Kamada, F., Serizawa, M., Hatakeyama, K., Ohnami, S., Maruyama, K., Mochizuki, T., Mizuguchi, M., Shiomi, A., Ohde, Y., Bando, E., Sugiura, T., Mukaigawa, T., Nishimura, S., Hirashima, Y., Mitsuya, K., Yoshikawa, S., Kiyohara, Y., Tsubosa, Y., Katagiri, H., Niwakawa, M., Takahashi, K., Kashiwagi, H., Yasunaga, Y., Ishida, Y., Sugino, T., Kenmotsu, H., Terashima, M., Takahashi, M., Uesaka, K. and Akiyama, Y. (2024): Evaluation of whole genome sequencing utility in identifying driver alterations in cancer genome. Sci. Rep., <b>14<\/b>, 23898.","DOI":"10.1038\/s41598-024-74272-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Nofziger, C., Turner, A.J., Sangkuhl, K., Whirl-Carrillo, M., Ag\u00fandez, J.A., Black, J.L., Dunnenberger, H.M., Ruano, G., Kennedy, M.A., Phillips, M.S., Hachad, H., Klein, T.E. and Gaedigk, A. (2020): PharmVar GeneFocus: CYP2D6. Clin. Pharmacol. Ther., <b>107<\/b>, 154-170.","DOI":"10.1002\/cpt.1643"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Ohnami, S., Hatakeyama, K., Nagashima, T., Maruyama, K., Isaka, M., Kamada, F., Nakatani, S., Shimoda, Y., Mizuguchi, M., Naruoka, A., Miyake, K., Ohshima, K., Ohnami, S., Akiyama, Y., Urakami, K. and Yamaguchi, K. (2025): Novel CYP2A7\/CYP2A6 germline hybrids associated with mutation burden in lung cancer revealed by whole-genome long-read sequencing. Sci. Rep., <b>15<\/b>, 44989.","DOI":"10.1038\/s41598-025-29542-w"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Ohnami, S., Nagashima, T., Urakami, K., Shimoda, Y., Kamada, F., Saito, J., Naruoka, A., Serizawa, M., Masuda, Y., Ohnami, S., Kusuhara, M. and Yamaguchi, K. (2017): Whole exome sequencing detects variants of genes that mediate response to anticancer drugs. J. Toxicol. Sci., <b>42<\/b>, 137-144.","DOI":"10.2131\/jts.42.137"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Ohnami, S., Naruoka, A., Isaka, M., Mizuguchi, M., Nakatani, S., Kamada, F., Shimoda, Y., Sakai, A., Ohshima, K., Hatakeyama, K., Maruyama, K., Ohde, Y., Kenmotsu, H., Takahashi, T., Akiyama, Y., Nagashima, T., Urakami, K., Ohnami, S. and Yamaguchi, K. (2022): Comparison of genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma in Japanese patients using a novel panel for cancer-related drug-metabolizing enzyme genes. Sci. Rep., <b>12<\/b>, 17928.","DOI":"10.1038\/s41598-022-22914-6"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Petrovi\u0107, J., Pe\u0161i\u0107, V. and Lauschke, V.M. (2020): Frequencies of clinically important CYP2C19 and CYP2D6 alleles are graded across Europe. Eur. J. Hum. Genet., <b>28<\/b>, 88-94.","DOI":"10.1038\/s41431-019-0480-8"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Robinson, J.T., Thorvaldsd\u00f3ttir, H., Winckler, W., Guttman, M., Lander, E.S., Getz, G. and Mesirov, J.P. (2011): Integrative genomics viewer. Nat. Biotechnol., <b>29<\/b>, 24-26.","DOI":"10.1038\/nbt.1754"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Taylor, C., Crosby, I., Yip, V., Maguire, P., Pirmohamed, M. and Turner, R.M. (2020): A review of the important role of CYP2D6 in pharmacogenomics. Genes (Basel), <b>11<\/b>, 1295.","DOI":"10.3390\/genes11111295"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Yamaguchi, K., Urakami, K., Ohshima, K., Mochizuki, T., Akiyama, Y., Uesaka, K., Nakajima, T., Takahashi, M., Tamai, S. and Kusuhara, M. (2014): Implementation of individualized medicine for cancer patients by multiomics-based analyses\u2014the Project HOPE\u2014. Biomed. Res., <b>35<\/b>, 407-412.","DOI":"10.2220\/biomedres.35.407"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Yang, Y., Botton, M.R., Scott, E.R. and Scott, S.A. (2017): Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing. Pharmacogenomics, <b>18<\/b>, 673-685.","DOI":"10.2217\/pgs-2017-0033"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/51\/10\/51_549\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:43:30Z","timestamp":1791002610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/51\/10\/51_549\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.51.549","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}